发明名称 |
Genotype- or phenotype-based drug formulation |
摘要 |
<p>The invention relates to a combination of two or more pharmaceutically active substances, of which at least one is a metabolic product ("metabolite") of the other ("parent substance"), in particular wherein the dosages thereof are selected in such a way that a genotypically or phenotypically determined variability of the conversion of the parent substance into the metabolite in certain individuals is compensated.</p> |
申请公布号 |
AU2013269793(A1) |
申请公布日期 |
2015.01.22 |
申请号 |
AU20130269793 |
申请日期 |
2013.05.27 |
申请人 |
BAYER TECHNOLOGY SERVICES GMBH |
发明人 |
WILLMANN, STEFAN;EISSING, THOMAS;DICKSCHEN, KRISTIN |
分类号 |
A61K31/138;A61P35/00 |
主分类号 |
A61K31/138 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|